A Healthy Volunteer Study of PBI-4050
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Fibrosis
- Inflammation
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: RandomizedIntervention Model: Sequential AssignmentIntervention Model Description: Cohorts will be dosed sequentially in an ascending fashion with approximately 14 days between starting dose at each dose level.Masking: Double (Participant, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 65 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04695041
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon